Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024
Worldwide prescription drug revenue - market risk from patent expiration 2010-2024
This statistic depicts the percentage of worldwide prescription drug revenue at risk due to patent expirations from 2010 to 2024. In 2012, around seven percent of the market was at risk due to patent expirations on pharmaceutical drug revenues.
Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024
Percentage of global prescription drug revenue at risk
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

June 2019

Region

Worldwide

Survey time period

as of May 2019

Supplementary notes

Total Sales at Risk’ represents the worldwide product sales in the year prior to patent expiry but allocated to the year of expiry. E.g. Plavix had sales of $7.1bn in 2011, this is shown as ‘At Risk’ in 2012.
* Projected.

Worldwide prescription drug revenue - market risk from patent expiration 2010-2024
This statistic depicts the percentage of worldwide prescription drug revenue at risk due to patent expirations from 2010 to 2024. In 2012, around seven percent of the market was at risk due to patent expirations on pharmaceutical drug revenues.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Global pharmaceutical industry
Global pharmaceutical industry

All Information
in one Presentation

Global pharmaceutical industry

Everything On "Global pharmaceutical industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Global pharmaceutical industry"
  • Overview
  • Companies and products
  • Top companies by revenue
  • R&D, patents, new products
The most important statistics
  • Outlook
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.